ReachMD and VerusMed Broadcast Medical Conference Coverage on XM Satellite Radio

VerusMed Conference Coverage Available to Physicians 24/7 on ReachMD

CHICAGO and NASHVILLE, Tenn. - February 6, 2008 - VerusMed and ReachMD, providers of advanced health care news and information for medical professionals, today announced a partnership to provide VerusMed's medical conference coverage highlights on ReachMD XM Satellite Radio (Channel 157) and via online streaming audio and on-demand podcasts. The companies will collaborate to deliver updated conference coverage 24/7 to physicians.  

The new conference series includes coverage of rheumatology, psychiatry and other therapeutic areas. Conference coverage will be aired daily in four, 13-minute audio segments. The programs include interviews, thought leader perspectives and peer insights on news released from the conference.  

"We're thrilled to be partnering with ReachMD to expand our clinical news briefings to physicians in another convenient information channel," said Scott McQuigg, CEO of VerusMed, a ConnectivHealth company. "For busy physicians, 24/7 XM radio programming that can be downloaded via podcast is an ideal way to catch up on conference coverage highlights." 

Through its experienced team of medical writers and editors, VerusMed delivers timely news coverage from key medical conferences to medical professionals who need to stay current on the groundbreaking research being conducted in their specialty areas. Each conference series will expand on key highlights as reported by VerusMed's editorial team.  

"This partnership is a great opportunity to deliver on our vision of giving medical professionals updated news from the nation's top medical conferences," said Gary Epstein, CEO of ReachMD. "VerusMed is an invaluable source of medical conference coverage for on-the-go medical professionals, and we share the same commitment to deliver much needed information in the most convenient ways."  

VerusMed's coverage will also be archived on ReachMD's website for one year after each conference airing.   

About VerusMed

VerusMed, an evolution of Faxwatch, provides timely, unbiased medical information to physicians, health care professionals, industry executives and patients. With its concise and objective editorial approach, VerusMed ensures that physicians and health care professionals receive the most relevant therapeutic updates. With more than 150,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. VerusMed is a ConnectivHealth company. To learn more, visit www.verusmed.com. 

About ReachMD

ReachMD, headquartered in Highland Park, Illinois, is a leading provider of advanced healthcare information and education for medical professionals. ReachMD XM 157 remains committed to its mission of delivering highly relevant education, information and communication to medical professionals. The ReachMD XM channel is a new and innovative media vehicle that continues to deliver on this mission. The company's proprietary technology provides the most up-to-date healthcare information in the field through a multi-channel platform that includes satellite radio and online programs accessed through any XM radio, digital media device or PC. Through this platform, healthcare professionals receive the latest information in best practices and new advances in treatment, delivered through convenient and accessible ways. For more information, visit www.reachmd.com. 

###

The Doctor's Channel and VerusMed Announce Partnership to Provide Physicians With Concise, Reliable Information
Multiple Channels of Information Allow Doctors to Learn From Peers In Formats Amenable to Hectic Schedules

NEW YORK, NY - January 10, 2008 - The Doctor's Channel (www.thedoctorschannel.com), hailed by CNBC as the "educational YouTube" for doctors, and VerusMed (www.verusmed.com), which provides timely, unbiased medical information to physicians, health care professionals and industry executives, today announced a partnership that will provide thousands of neurologists with short, 1-2 minute streaming videos that summarize articles included in VerusMed's weekly publication, VerusMed Neurology Update.

"Today's physician often doesn't have the time to sift through pages of medical research to find the bottom line, but it's crucial they stay up-to-speed on medical advances, in order to best serve their patients," explained The Doctor's Channel President David Best, MD, MBA. "The marriage of VerusMed Neurology Update and The Doctor's Channel is the next logical step in providing bite-sized information to time-starved physicians by letting them choose the format that best suits their lifestyle."

VerusMed Neurology Update is a weekly publication, covering major neurological conditions, including Alzheimer's disease, migraine, multiple sclerosis, Parkinson's disease and epilepsy. The publication is distributed via fax and email to thousands of neurologists, summarizing research published in major peer-reviewed medical journals in the form of clinical news briefs.

In order to create a seamless network of information for physicians, VerusMed will provide clinical news briefs from VerusMed Neurology Update to The Doctor's Channel, which will then create short videos summarizing key briefs. The videos will be viewable online at The Doctor's Channel and at the newly redesigned and expanded VerusMed Web site, where physicians access and read clinical news briefs across multiple therapeutic categories.

"With only a few moments to spare in between rounds or appointments, doctors have to be very selective with their sources of information," said Scott McQuigg, CEO of VerusMed. "Our partnership with The Doctor's Channel provides us with yet another avenue to offer doctors pertinent information in a format that's conducive to a hectic schedule."

Doctors who register on The Doctor's Channel can personalize their experience by joining groups related to individual interests, sending and receiving personalized messages, and storing their favorite videos. When viewing certain pharmaceutical company sponsored videos, doctors can even request additional information or samples from a sales representative with just one click of the mouse.

The Doctor's Channel and thedoctorschannel.com are trademarks or registered trademarks of The Doctor's Channel, LLC in the United States and/or other countries. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

About The Doctor's Channel
The Doctor's Channel (www.thedoctorschannel.com) is a Web site that allows doctors to "Learn from each other. Fast." The site includes short, concise, one- to two-minute streaming video clips designed to get to the point with insights and opinions from experts in 35 different specialties as well as community and lifestyle features that help doctors stay on top of the latest news, ideas and information. The Doctor's Channel is based in New York and was founded by David Best, MD, MBA, and Michael Banks, MD. David Best serves as the company president. Dr. Best has worked in health care advertising, marketing and education for 25 years and founded Saatchi & Saatchi's medical education company BESTMED. Dr. Best was Medical Services Director at Bristol-Myers Squibb and Dr. Banks worked for Pharmacia and Pfizer.

About VerusMed
VerusMed, an evolution of Faxwatch, provides timely, unbiased medical information to physicians, health care professionals and industry executives. VerusMed's concise and objective editorial approach ensures that readers receive the most relevant therapeutic updates. With more than 150,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. VerusMed is a ConnectivHealth company. To learn more, visit www.verusmed.com or call 800-763-3329.

###

VerusMed Unveils Evidence Grading System And Newly Redesigned VerusMed.com

NASHVILLE, Tenn., January 8, 2008 -- VerusMed, a ConnectivHealth company, today announced the launch of its groundbreaking evidence grading system for all VerusMed clinical news briefs. VerusMed's evidence grading scale is among the first to be introduced to U.S. physicians through an easy-to-access medical information service. The launch coincides with the release of the newly redesigned and expanded VerusMed Website, verusmed.com.

VerusMed, which provides clinical news briefs to physicians and other health care professionals in dozens of therapeutic categories, is continuously enhancing all aspects of its physician information services. With its new evidence grading system, each clinical study reported on will be reviewed for quality of evidence and then assigned an appropriate grade, using a four-point scale.

"By providing evidence grades to our clinical news briefs, physician readers will be able to quickly and efficiently review the quality of the literature being discussed," said June Manning, VerusMed editor-in-chief. "With the addition of the evidence grading system, each of VerusMed's clinical news stories will receive an evidence grade that will appear next to the headline," she added.

Manning noted that VerusMed's innovative evidence grading system is similar to grading systems used by the U.S. Preventive Services Task Force (USPSTF), the American Medical Association, British Medical Journal, the Agency for Healthcare Research and Quality (AHRQ), and the Cochrane Collaboration, among others.

Jeff Andrews, M.D., chair of VerusMed's editorial advisory board and senior fellow of the Vanderbilt Center for Evidence-Based Medicine, developed VerusMed's evidence grading system, using standards created by the internationally recognized Grading of Recommendations Assessment, Development and Evaluation Working Group, also known as GRADE (http://www.gradeworkinggroup.org), of which he is a member.

"Medical evidence, or the recommendations that are based on the evidence, can be of different quality levels," said Andrews. "Since poor quality evidence can lead to recommendations that are not in a patient's best interest, it is essential for physicians to know whether a study is strong or weak."

Andrews explained that sources of evidence range from small laboratory studies, or case reports, to well-designed, large clinical studies. "Based on the grade that is assigned, physicians can decide whether they want to continue reading the article or reference it for future reading," he said.

A number of factors are considered when assigning an evidence grade:

• Study design - therapeutic, prognostic, diagnostic or economic/decision analysis
• Number of study patients and the percentage of follow-up
• Statistical power
• Bias and influence
• Effect size
• Balance of benefits and risks

"Physicians have continually expressed to us that their most precious limited resource is time," said Scott McQuigg, CEO of ConnectivHealth. "We developed our new evidence grading system so that physicians can quickly determine the relevancy of information and invest their time in the studies that will have the greatest impact in their practice and for their patients."

In addition to the new evidence grading system, VerusMed's redesigned verusmed.com has many new features designed to help physicians quickly access relevant medical news and information by therapeutic area. The site's expanded features include online video, most read stories, most e-mailed stories and searchable archives.

About VerusMed
VerusMed, an evolution of Faxwatch, provides timely, unbiased medical information to physicians, health care professionals and industry executives. VerusMed's concise and objective editorial approach ensures that readers receive the most relevant therapeutic updates. With more than 150,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. VerusMed is a ConnectivHealth company. To learn more, visit www.verusmed.com or call 800-763-3329.

About ConnectivHealth
ConnectivHealth is a network of powerful health information brands that enables the delivery, distribution and organization of important health information for physicians, health care professionals, hospitals and schools through customized channels. Each brand serves a critical information need in the marketplace with the single goal of improving health. Privately held, the ConnectivHealth network includes: PeerClip, HealthTeacher, VerusMed and Discovery Hospital, a partnership with Discovery Communications. The company's investors include Petra Capital Partners of Nashville, Chrysalis Ventures of Louisville, Ky., and members of the management team. For more information, e-mail us at info@connectivhealth.com.

###

Primary Care Physicians Need Better Access to More Concise, Timely Medical Information
VerusMed survey uncovers challenges in delivering crucial information

NASHVILLE, Tenn., October 2, 2007 -- As the vanguard among health care practitioners, primary care physicians face a daunting task. Not only must they know how to diagnose and treat a multitude of health conditions in patients of all ages, but they must also stay informed of the changes and advances that continually outdate current treatment guidelines.

A VerusMed information needs survey of primary care physicians found that even though the majority of the physicians polled spend one to three or more hours per week reading medical research and news, they still believe that gaps exist in the information they receive, citing dozens of specific examples such as a lack of information on patient safety, psychiatry and specific conditions such as diabetes. They also say they are lacking in postmarketing data and information pertaining to evidence-based medicine. Furthermore, physicians voiced concern regarding the time it takes for news and updates to reach them.

"It is not a huge surprise that primary care physicians point to so many information gaps given the numerous resources they must sort through to find relevant information," said June Manning, VerusMed's editor-in-chief. "The sheer diversity of what these physicians must know can seem intimidating, not to mention the speed at which medical science continues to evolve. It's definitely a challenge just trying to keep up."

When asked which areas they are most interested in reading about, the primary care physicians who participated in the information needs assessment chose effectiveness of drug treatments, followed closely by prevention and diagnosis of medical conditions. They are also interested in information about screening, side effects of treatments and quality of care. The type of information they consider most valuable includes treatment guidelines, FDA news, systematic reviews, meta-analyses, case studies and Phase III studies.

Moreover, the survey revealed that primary care physicians, like physicians in more specialized practices, still rely on medical journals, conferences and other peer interactions as their primary resources for gaining new knowledge. Primary care physicians also are similar to specialists in that they have not fully embraced new media technology. The majority of those polled said they still prefer to receive their information through the mail, followed closely by e-mail.

"The findings show that primary care physicians still rely on select information resources and delivery modes," said Scott McQuigg, CEO of ConnectivHealth, parent company of VerusMed, which provides clinical news briefs to physicians and other health care professionals. "Therefore, anyone wanting to connect to primary care physicians must work within these specific channels while increasing the selectivity of their information-and the precision with which they deliver it."

During the last decade, VerusMed has used its ongoing survey process to shape content development and delivery of future publications for physicians in multiple and diverse therapeutic areas. To request a full report, e-mail us at physiciandata@verusmed.com.

About VerusMed
VerusMed, an evolution of Faxwatch, provides timely, unbiased medical information to physicians, health care professionals and industry executives. VerusMed's concise and objective editorial approach ensures that readers receive the most relevant therapeutic updates. With more than 150,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. VerusMed is a ConnectivHealth company. To learn more, visit www.VerusMed.com or call 800-763-3329.

About ConnectivHealth
ConnectivHealth is a network of powerful health information brands that enable the delivery, distribution and organization of important health information for physicians, health care professionals, hospitals and schools through customized channels. Each brand serves a critical information need in the marketplace with the single goal of improving health. Privately held, the ConnectivHealth network includes: PeerClip, HealthTeacher, VerusMed and Discovery Hospital, a partnership with Discovery Communications. The company's investors include Petra Capital Partners of Nashville, Chrysalis Ventures of Louisville, Ky., and members of the management team. For more information, visit www.connectivhealth.com.

###

ConnectivHealth Raises $2.1 Million for New Products and Acquisitions
Investors Include Chrysalis Ventures and Petra Capital

NASHVILLE, Tenn., July 20, 2007 -- ConnectivHealth, a health care information company, today announced it has raised $2.1 million in financing to accelerate its expansion in the national health care digital media space. The news follows ConnectivHealth's recent acquisition of Nashville-based Relegent, which delivers online health care information to the hospital and education industries. In addition to original company investors, Chrysalis Ventures, Petra Capital Partners, and Scott McQuigg, the company's President and CEO, other members of the management team also participated in the financing.

"The financing comes at an opportune time as we prepare to launch several innovative Web products for physicians and consumers," said McQuigg.

McQuigg added that part of the funding also went toward the recently acquired Relegent and its two core brands: HealthTeacher, which provides K-12 health curriculum online to more than 7,000 schools; and Discovery Hospital, offering consumer health content via more than 150 hospital Websites in partnership with Discovery Communications Inc.

"The continued support of our investors enables us to acquire and market unique companies that align with our vision of connecting physicians, schools, hospitals and consumers through a common health care information platform. At the same time, it also allows us to aggressively grow our customer base through new products," said McQuigg.

In other news, the company is relocating its headquarters from Scottsdale, Ariz., to Nashville and will be moving into a new 7,000 square-foot office in the Nashville area to accommodate recent growth. McQuigg noted that ConnectivHealth will add 10 new positions this year, with as many to follow in 2008.

In addition to its online hospital and education products, ConnectivHealth reaches 150,000 physicians through VerusMed, a company which delivers independent clinical news briefs.

About ConnectivHealth
ConnectivHealth is building a network of health care information and new media businesses that enable the delivery, distribution, and organization of important health information for physicians, health care professionals, hospitals, schools, and consumers. The ConnectivHealth network includes HealthTeacher, VerusMed and Discovery Hospital. The company's investors include Petra Capital Partners of Nashville, Chrysalis Ventures of Louisville, Ky., and members of the management team. For more information, e-mail us at info@connectivhealth.com.

About Petra Capital Partners
Based in Nashville, Tenn., Petra Capital Partners provides growth capital to business, information, and health care services companies throughout the United States. Petra specializes in helping proven entrepreneurs build sustainable growth companies by serving as a trusted advisor and a reliable source of capital. Petra targets transaction sizes under $10 million in the form of equity or subordinated debt with warrants in high growth companies to fund organic growth, acquisitions, or in certain cases, owner recapitalizations. For more information, please visit www.petracapital.com.

About Chrysalis Ventures
Founded in 1993, Chrysalis Ventures is a leading source of equity capital for young growth companies in the Midwest and South. Chrysalis invests primarily in early-stage and expansion-stage companies in health care services and technology, media and communications, and business services. With headquarters in Louisville, Ky., and a second office in Cleveland, Chrysalis has more than $300 million under management and has made investments in over 50 companies. For more information, please visit www.chrysalisventures.com.

###

VerusMed Names Dr. Jeff Andrews Chair of Editorial Advisory Board
Dr. Andrews Will Also Serve as Interim Medical Director

NASHVILLE, Tenn., July 12, 2007 -- VerusMed has named Vanderbilt University's Jeff Andrews, M.D., as Chair of its Editorial Advisory Board. Dr. Andrews, a board certified OB/GYN, is an Associate Professor of Medical Education and Administration, and the Senior Physician of the Vanderbilt Center for Evidence-Based Medicine. Dr. Andrews will also serve as VerusMed's interim Medical Director.

"Dr. Andrews' leadership in evidence-based health care and his clinical care experience provides a tremendous asset to VerusMed's Editorial Team and subsequently will benefit our readers," said June Manning, Editor-in-Chief at VerusMed, which delivers clinical briefs and medical news to physicians and health care professionals.

"Working with VerusMed will give me a unique opportunity to spread my passion for evidence-based health care," said Dr. Andrews, who is also an Associate Professor of Obstetrics and Gynecology at Vanderbilt. "June and I are working on some very exciting projects that the Editorial Team is looking forward to implementing."

As Chair of VerusMed's Editorial Advisory Board, Dr. Andrews will work with VerusMed's Editorial Team and members of its Editorial Advisory Board to continue to ensure the company's information offerings meet high standards for objectivity, relevance and timeliness.

"Dr. Andrews has a keen understanding of how physicians use information in clinical practice and a passion for providing the best information to doctors so they can make informed decisions," said Scott McQuigg, President and CEO of VerusMed. "His knowledge and experience will be invaluable to us as we grow our core business and expand our product offerings to meet the information needs of physicians."

Before joining Vanderbilt, Dr. Andrews held many leadership roles, including Medical Director of Women's Services and Clinical Advisor for Evidence-Based Medicine Guidelines at Duke University Medical Center. Prior to his 11 years at Duke, Dr. Andrews spent five years in clinical practice in Canada.

Dr. Andrews received his medical degree from the University of Toronto, where he also completed his internship and residency in Obstetrics and Gynecology. Dr. Andrews is a Fellow of the American College of Obstetricians and Gynecologists and is board certified by the Royal College of Physicians and Surgeons of Canada.

About VerusMed
VerusMed, an evolution of Faxwatch, provides timely, unbiased medical information to physicians, health care professionals, industry executives and patients. With its concise and objective editorial approach, VerusMed ensures that physicians and health care professionals receive the most relevant therapeutic updates. With more than 150,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. VerusMed is a ConnectivHealth company. To learn more, visit www.VerusMed.com.

###

ConnectivHealth Acquires Relegent
Acquisition Includes HealthTeacher and Discovery Hospital Products

NASHVILLE, Tenn., June 26, 2007 -- ConnectivHealth today announced it has acquired Relegent, a Nashville, Tenn.-based provider of health care information to the hospital and education industries. Terms of the deal were not disclosed.

"We are excited to have Tod Fetherling and the Relegent family join ConnectivHealth," said Scott McQuigg, president and CEO. "HealthTeacher and Discovery Hospital are well-respected brands in health information and significantly strengthen our capabilities to deliver a wider continuum of health information to physicians, schools, and hospitals. Tod's decade of experience in online health information and his health care marketing acumen adds tremendous value to the ConnectivHealth leadership team," he added.

"Health and education are the two fastest growing segments of the GDP, totaling approximately 22 percent of total expenditures," said J. Tod Fetherling, President of Relegent. "By joining ConnectivHealth, we strengthen our focus on health education for schools and hospitals, which must become a key priority for our society over the next several decades. We have found direct correlations between health education and improved health outcomes."

As Chief Product Officer of ConnectivHealth, Fetherling will work with the combined company's customers and business partners, as well as industry leaders to continue to ensure that ConnectivHealth products empower consumers and health care providers to improve health and well-being.

HealthTeacher delivers K-12 health curriculum online, including lesson plans and related materials to more than 7,000 schools in more than 60 countries. HealthTeacher was built on the National Health Education Standards and is backed by more than nine years of high-quality work and commitment to teachers and students. Discovery Hospital is a long-standing partnership with Discovery Communications Inc., which delivers health content to consumers via more than 150 hospital websites. The Discovery Health Channel is also a Discovery Communications brand. Additionally, the acquisition includes Relegent's interest in Planning 2.0, which provides market planning software and consulting to the health care industry.

About ConnectivHealth:
ConnectivHealth is building a network of health care information and new media businesses that enable the delivery, distribution, and organization of important health information for physicians, health care professionals, hospitals, and consumers. ConnectivHealth's initial holding, VerusMed, founded in 1994, delivers editorially independent clinical news briefs to more than 150,000 physicians. When complete, the ConnectivHealth network will include a health care information platform, connecting a full spectrum of dynamic health care content. The company's investors include Petra Capital Partners of Nashville, Chrysalis Ventures of Louisville, Ky., and Scott McQuigg. For more information, e-mail us at info@connectivhealth.com.

About Relegent
Founded by J. Tod Fetherling, Relegent is a leading health care information and marketing firm based in Nashville. Relegent owns and operates HealthTeacher, the leading K-12 online health curriculum. The company also exclusively markets Discovery Hospital content to hospitals and provides additional health care marketing services to hospitals, health plans, and employers. Prior to Relegent, Fetherling held several senior-level consulting and interactive marketing roles within the health care industry, including Vice President of Business Development at First Consulting Group (FCG), a health care technology consulting practice. He also served as Chief Executive Officer of Galaxy.com, the first searchable Internet directory, which was part of America's Health Network (AHN.com) and set a record for attracting the most visitors ever to a single live broadcast event on the Internet by broadcasting the birth of a child – a significant first. Fetherling was also Senior Vice President of America's Health Network, overseeing the Interactive operations of one of the largest Cable/Internet Health companies. Fox/News Corp. later became co-owner of Galaxy and AHN. Earlier in his career, he served as Director of Interactive Marketing at HCA Inc., where he implemented one of the Internet's first major health portals.

###

VerusMed Holding Company Becomes ConnectivHealth
New Growth Signals Name Change for FWI

NASHVILLE, Tenn., June 19, 2007 -- FWI Inc., the parent company of VerusMed, today announced it has changed its name to ConnectivHealth.

The new ConnectivHealth name better positions the company in the health care market as it embarks on a multimillion-dollar growth trajectory, which includes several pipeline acquisitions and a suite of new products all aimed at providing relevant health care information to physicians, other health care professionals, and consumers.

"As we prepare for new growth, we need a name that more accurately represents the unifying nature of our current and future businesses," said President and CEO Scott McQuigg. "ConnectivHealth best describes the connectivity of our products and our business strategy of integrating multiple health care information offerings."

ConnectivHealth currently serves as the parent company of VerusMed, which delivers clinical briefs and medical news to physicians and health care professionals. ConnectivHealth investors include Petra Capital Partners of Nashville, Chrysalis Ventures of Louisville, Ky., and Scott McQuigg. In addition to McQuigg, ConnectivHealth's officers include Bob Kinard, Vice President and CFO, and Paul Mattioli, Vice President of Sales.

About ConnectivHealth:
ConnectivHealth is building a network of health care information and new media businesses that enable the delivery, distribution, and organization of important health information for physicians, health care professionals, hospitals, and consumers. ConnectivHealth's initial holding, VerusMed, founded in 1994, delivers editorially independent clinical news briefs to more than 150,000 physicians. When complete, the ConnectivHealth network will include a health care information platform, connecting a full spectrum of dynamic health care content.

About Petra Capital Partners:
Based in Nashville, Tenn., Petra Capital Partners provides growth capital to business, information, and health care services companies throughout the United States. Petra specializes in helping proven entrepreneurs build sustainable growth companies by serving as a trusted advisor and a reliable source of capital. Petra targets transaction sizes under $10 million in the form of equity or subordinated debt with warrants in high growth companies to fund organic growth, acquisitions, or in certain cases, owner recapitalizations. For more information, please visit www.petracapital.com.

About Chrysalis Ventures
Founded in 1993, Chrysalis Ventures is a leading source of equity capital for young growth companies in the Midwest and South. Chrysalis invests primarily in early-stage and expansion-stage companies in health care services and technology, media and communications, and business services. Based in Louisville, Ky., Chrysalis has more than $250 million under management and has made investments in over 50 companies. For more information, please visit www.chrysalisventures.com.

###

Time-Starved Oncologists Still Not Receiving Crucial Medical Information -- VerusMed Survey Reveals Vital Health Care Information Gaps

(Nashville, Tenn., March 7, 2007) -- Despite having no shortage of medical news and information resources, oncologists still say they are missing key health care information in several areas that are critical to their clinical practice, finds a VerusMed information needs survey of more than 100 oncologists.

Even though nearly half of oncologists surveyed spend three or more hours per week trying to keep current with advancements in cancer treatment, many say that they are still lacking essential information regarding post-marketing studies, toxicity management and reimbursement, among other areas.

"This means that the right information in many cases isn't getting through or isn't readily available to oncologists," said Scott McQuigg, CEO of VerusMed, which provides clinical briefings to physicians and other health care professionals. "Because of the demands of their practice and patient care, oncologists are limited in the amount of time they can invest in routine medical reading. Considering this, it's incumbent on anyone who provides information to oncologists to be more specific about what, when, and how medical information is delivered."

The physician needs assessment asked oncologists to identify information gaps in the oncology community, revealing physician perspectives on promising drug treatments and the types of cancer information they are most interested in reading.

"Out of the several information gaps oncologists identified in the survey, information on post-marketing studies was one of the more significant areas because it focuses on real-world clinical experience," said Sean Tape, Oncology Editor at VerusMed. "Physicians want to know how patients throughout the entire population are responding to a drug."

The survey also found that out of the numerous ways to receive medical information, oncologists still rely on medical journals, conferences and other peer interactions as their primary knowledge resources.

Surprisingly, the physician information needs assessment also discovered that oncologists are not adopting new media technology very quickly. When asked to pick their top two preferences for receiving medical information, many said they still rely on traditional and electronic mail, followed closely by fax delivery.

"What this tells us is that although PDAs, Web portals, and product Web sites hold a lot of promise for improving information dissemination, these mediums have not yet proven enough value for busy oncologists to change their information consumption habits," said McQuigg.

Over the last decade, VerusMed has used its ongoing survey process to inform content development and delivery of future publications for oncologists, neurologists and rheumatologists, among many other specialists. To request a full report, go to physiciandata@verusmed.com.

About VerusMed
VerusMed, an evolution of Faxwatch, provides timely, unbiased medical information to physicians, health care professionals, industry executives and patients. With its concise and objective editorial approach, VerusMed ensures that physicians and health care professionals receive the most relevant therapeutic updates. With more than 200,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. The company has twice been named to the Inc. 500 list of America's fastest growing companies. To learn more, visit www.VerusMed.com or call 800-763-3329.

Media Contact:
Michelle Ponte, Communications Director
VerusMed
(615) 429-1095
michelle.ponte@verusmed.com

###

VerusMed Names Industry Veteran Bob Kinard Vice President and Chief Financial Officer

(Nashville, Tenn., and Scottsdale, Ariz., January 18, 2007) -- VerusMed, a medical information provider, has announced that they have named Bob Kinard as the company's Vice President and Chief Financial Officer (CFO). Kinard, previously with Passport Health Communications, Inc., will primarily be responsible for overseeing financial strategies and corporate development for the fast growing healthcare company.

Kinard's professional background includes experience in mergers and acquisitions, strategic partnerships and healthcare corporate finance transactions. Previously, he served as Chief Corporate Development Officer with Passport Health Communications, Inc., a healthcare IT services company, based in Nashville, Tenn. Additionally, Kinard served as Director of Business Development and as a Director of Financial Operations with PhyCor, Inc., a national multi-specialty practice management company. Prior to these positions, Kinard served as a Director in the Health Ventures practice of KPMG.

"Bob's background as part of leadership teams that have built high growth health care businesses and his knowledge of how critical information and connectivity can improve healthcare delivery are invaluable experiences for VerusMed," said Scott McQuigg, President and CEO of VerusMed. "His experience in financial leadership, acquisitions and developing strategic partnerships will be a key component in continuing our strong growth."

Kinard holds a bachelor's degree in Finance from Florida State University and a master's degree in Business Administration from the University of Alabama. He also holds a CPA license.

About VerusMed
VerusMed, An Evolution of Faxwatch, provides timely, unbiased medical information to physicians, healthcare professionals, industry executives and patients. With its concise and objective editorial approach, VerusMed ensures that physicians and healthcare professionals receive the most relevant therapeutic updates. With more than 200,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. The company has twice been named to the Inc. 500 list of America's fastest growing companies. To learn more, visit www.VerusMed.com or call 800-763-3329.

Media Contact:
Silas Deane
Logic Media Group
(615) 244-8055 ext. 400
Silas@logicmediagroup.com

###

VerusMed Discovers Critical Information Gaps to Physicians in Cardiology, Psychiatry, Endocrinology and Dermatology

(Nashville, Tenn., October 23, 2006) -- VerusMed, a medical information provider to physicians and other health care professionals, announced the results of a recently conducted physician information needs assessment in four therapeutic areas; cardiology, psychiatry, endocrinology and dermatology. The results revealed a large number of information gaps in each specialty and unveiled preferences from physicians and health care providers on how they would like to receive new and relevant information on updates and breakthroughs in their specialties. As a result, the survey insights are particularly valuable to pharmaceutical companies, health plans and hospital systems who routinely communicate with physicians.

"With the pressures of practicing medicine making literature research increasingly more difficult, we found that 42% of physicians are spending more than three hours per week just trying to keep up with medical information," said Scott McQuigg, CEO of VerusMed. "Our needs analyses highlight important considerations for companies who communicate with physicians." The analyses further revealed that with so much information coming from clinical journals, promotional messaging, patient requests and directives from health systems and health plans, time-starved physicians appreciate help focusing their reading on topics of greatest interest and relevance to their specialty. "The issue we uncovered is not the volume of information, but that physicians appreciate appropriate information organized and delivered based on their preferences," said McQuigg.

Leveraging its 12-year expertise in developing concise, timely and objective information for physicians, coupled with results from the physician information needs analyses, VerusMed is developing a series of publications for physician specialists in Psychiatry, Endocrinology, Cardiology, and Dermatology. By understanding information topics of greatest interest, preferred publication length and delivery channel by therapeutic area, VerusMed will continue to provide concise, relevant and easy-to-access publications designed to meet clinician information needs.

A copy of the physician information needs assessment by therapeutic area is available from VerusMed by contacting Jeffrey Caplan, Vice President of Product Development and Marketing at 615-482-1925 or jeff.caplan@verusmed.com.

About VerusMed
VerusMed, an evolution of Faxwatch, provides timely, unbiased medical information to physicians, health care professionals, industry executives and patients. With its concise and objective editorial approach, VerusMed ensures that physicians and health care professionals receive the most relevant therapeutic updates. With more than 200,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. The company has twice been named to the Inc. 500 list of America's fastest growing companies. To learn more, visit www.VerusMed.com or call 800-763-3329.

Media Contact:
Silas Deane
Logic Media Group
(615) 244-8035
Silas@logicmediagroup.com

###

VerusMed Names Paul Mattioli Vice President of Sales

(Nashville, Tenn., September 19, 2006) -- VerusMed, a leader in providing medical information to physicians and other health care professionals, today announced the addition of Paul Mattioli as Vice President of Sales.

"Paul understands how to maximize the value of integrated media communications," said Scott McQuigg, President and CEO of VerusMed. "With nearly 15 years of proven interactive media and marketing experience in health care, he will be an asset to our executive team as we provide solutions to help our customers connect with physicians."

Mattioli's professional background includes developing and leading the sales efforts of integrated media and information solutions across the health care industry. Previously, he served as Vice President of Sales for HealthLeaders-Interstudy & HealthLeaders Inc., a healthcare media and business information company, based in Nashville, Tenn. Additionally, Mattioli served as Director of Healthcare Marketing Strategy for Morrison Management Specialists and held sales and sales leadership roles in interactive media including Forbes.com, Ziff-Davis, and Epsilon Interactive.

Mattioli holds bachelor's degree in English and Communications from Muhlenberg College in Allentown, Pa. where he was a four-year scholar athlete.

About VerusMed
VerusMed, An Evolution of Faxwatch, provides timely, unbiased medical information to physicians, healthcare professionals, industry executives and patients. With its concise and objective editorial approach, VerusMed ensures that physicians and healthcare professionals receive the most relevant therapeutic updates. With more than 200,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. The company has twice been named to the Inc. 500 list of America's fastest growing companies. To learn more, visit www.VerusMed.com or call 800-763-3329

Media Contact:
Audra Wait
Logic Media Group
(615) 244-8055
audra@logicmediagroup.com

###

VerusMed Names Jack E. Angel to Board of Directors

(Nashville, Tenn., August 24, 2006) -- VerusMed, a leading provider of medical information to physicians and other healthcare professionals, announced today that Jack E. Angel has joined its board of directors.

"The experience Jack brings to the VerusMed board of directors is highly valued. Jack is a well-regarded leader in healthcare communications and media, and has played an important role in helping build some of the industry's most successful companies," said Scott McQuigg, President and CEO of VerusMed. "His experience providing valuable information to physicians and healthcare professionals and his knowledge of the issues facing the healthcare communications industry will be a strong asset for our company."

Angel is President of Greenwich Communications (GCL), based in Greenwich, Conn., a healthcare communications and consulting firm. Prior to founding GCL, Angel served as Executive Vice President for Medical Economics Company, based in Montvale, N.J., a leading medical publisher. In addition, he served as President for Patient Care Communications, Inc., based in Darien, Conn., a healthcare information and education company dedicated to physicians and physician networks; President of International Thomson Technology Information, Inc.; and Publisher of Physicians Desk Reference (PDR) and Drug Topics.

Angel currently serves as a Board Director for various companies, including Gold Standard Multimedia (recently acquired by Elsevier) in Tampa, Fla., Wicks Medical Information in New York, N.Y., Current Psychiatry, in Montvale, N.J., and Global Edge, Inc., in New York, N.Y.

Angel is active in several industry organizations and is currently the Executive Director of the Coalition for Healthcare Communications Foundation, based in New York, N.Y., a non-profit educational foundation that conducts research on the quality and value of healthcare marketing communications. Additionally, Angel was one of the original members of the Working Group on Communication of Ethical Guidelines for Gifts to Physicians from Industry, and served as President of the Association of Medical Publications and the Pharmaceutical Advertising Council.

Angel holds a M.B.A. from New York University in Manhattan, N.Y., and an M.E. degree from State University of New York in New York, N.Y.

Angel joins existing VerusMed board members Koleman Karleski, John Marchica, Scott McQuigg and Rob Smith.

About VerusMed
VerusMed, An Evolution of Faxwatch, provides timely, unbiased medical information to physicians, healthcare professionals, industry executives and patients. With its concise and objective editorial approach, VerusMed ensures that physicians and healthcare professionals receive the most relevant therapeutic updates. With more than 200,000 readers across several dozen therapeutic and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. The company has twice been named to the Inc. 500 list of America's fastest growing companies. To learn more, visit www.VerusMed.com or call 800-763-3329

Media Contact:
Audra Wait
Logic Media Group
(615) 244-8055
audra@logicmediagroup.com

###

Medical Information Provider, Faxwatch, Changes Name to VerusMed

Company Also Announces New Investors and Leadership

(Scottsdale, Ariz., April 3, 2006) -- Faxwatch, a leader in providing medical information to physicians and other healthcare professionals, announced today that they have changed the name of the company to VerusMed. Company executives decided it was time to evolve the Faxwatch name to VerusMed, a name that better reflects its market connectivity and commitment to being a trusted source for medical news and information.

VerusMed stands for "Truth in Medicine" and further emphasizes the company's core values of providing objective and relevant medical news and information. With plans in place to expand the company's service lines over the next year, leaders of the company felt they needed a name that demonstrates the company's growing information delivery capabilities and will serve as a platform for future product offerings.

The company also announced that it has received a majority investment from two different investment groups. Petra Capital Partners of Nashville, Tenn., and Chrysalis Ventures of Louisville, Ky., joined the company's founder, John Marchica, as investors. Terms of the investments have not been disclosed. However, the two investment firms have identified it as significant and plan to continue to invest in the company's growth and expand the company's product offerings. The investors have named healthcare information industry veteran Scott McQuigg as the company's President and CEO, replacing Marchica, who is pursuing a Ph.D. in clinical epidemiology at Dartmouth Medical School and who remains a member of the company's Board of Directors. McQuigg was most recently the founder and former CEO of HealthLeaders, a leading healthcare business media and research company.

"VerusMed has a proven history of helping time-starved physicians and healthcare professionals cut through the clutter, getting to the essence of medical news and information so they can focus on patient care. As we grow our information service offerings, VerusMed will continue its work in helping companies in the pharmaceutical, biotechnology and managed care industries build rapport with our audience of healthcare professionals," said McQuigg.

"Our mission has not changed and we will continue providing relevant, concise and objective medical information," said June Manning, VerusMed Editor-in-Chief. "Our goal is to help healthcare professionals focus their medical reading and education, and doing so in a format that saves them time and improves patient care."

VerusMed, founded in 1994, helps physicians and healthcare professionals stay abreast of the latest medical advancements across key therapeutic areas and industry segments. Ranging from Neuroscience to Men's Health to Oncology and more than 40 other specialty service areas, VerusMed's publications are all produced by the company's staff of highly experienced medical writers and editors on a daily basis. Each publication is designed to provide insight about the latest trends, clinical trial results and other need-to-know health updates in an objective format for the audiences they serve.

About VerusMed
VerusMed, An Evolution of Faxwatch, provides timely, unbiased medical information to physicians, healthcare professionals, industry executives and patients. With its concise and objective editorial approach, VerusMed ensures that physicians and healthcare professionals receive the most relevant therapeutic updates. With more than 150,000 readers across several dozen therapeutic- and industry segment-specific publications, VerusMed is able to leverage its market connectivity to help companies in the pharmaceutical, biotechnology, hospital and managed care industries to establish brands and build rapport with key audiences. The company has twice been named to the Inc. 500 list of America's fastest growing companies. To learn more, visit www.verusmed.com or call 800-763-3329.

About Petra Capital Partners
Petra Capital Partners provides growth capital to business, information, and healthcare services companies throughout the United States. Petra specializes in helping proven entrepreneurs build sustainable growth companies by serving as a trusted advisor and a reliable source of capital. Petra targets transaction sizes under $10 million in the form of equity or subordinated debt with warrants in high growth companies to fund organic growth, acquisitions, or in certain cases, owner recapitalizations. The partners at Petra have a proven track record of success spanning a 20 year period of time and covering 66 companies and $230 million of invested capital. Based in Nashville, Tenn., Petra seeks to invest in companies with the following financial characteristics: annual revenue in excess of $5 million, positive EBITDA, and growth in excess of 25% per annum. For more information, please visit www.petracapital.com.

About Chrysalis Ventures
Founded in 1993, Chrysalis Ventures is a leading source of equity capital for young growth companies in the Southeast and Midwest. Chrysalis invests primarily in early-stage and expansion-stage companies in healthcare services and technology, media and communications, and business services. Based in Louisville, Ky. Chrysalis has more than $200 million under management and has made investments in over 50 companies. For more information, please visit www.chrysalisventures.com.

Media Contact:
Silas Deane
Logic Media Group
(615) 244-8035
Silas@logicmediagroup.com

###